secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anika Therapeutics, Inc. (ANIK)
CIK:        0000898437
Form:       8-K
Filed at:   2021-11-01T23:59:59+00:00
Accession:  0001171843-21-007366
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anika Therapeutics appoints Sheryl Conley to Board of Directors; adds orthopedic industry expertise
--------------------------------------------------------------------------------

- Appointed Sheryl Conley as independent director effective Oct 28, 2021; board expands from seven to eight members.
- Ms. Conley brings over 35 years of orthopedic experience, including 25 years at Zimmer as Group President and CMO.
- She will serve on the Audit Committee and received 8,179 restricted stock units vesting over three years.
- Currently President of AcceLINX and board member at Neuronetics (STIM) and Surgalign (SRGA).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/0001171843-21-007366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/f8k_110121.htm
  HTML page:      https://secwatch.observer/filing/0001171843-21-007366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer